Towards a molecular therapy for glycogen storage disease type II (Pompe disease)

This publication has 33 references indexed in Scilit:

• Immune Response to Enzyme Replacement Therapy in Lysosomal Storage Disorder Patients and Animal Models
  Molecular Genetics and Metabolism, 1999
• Dystrophin expression in the mdx mouse restored by stem cell transplantation
  Nature, 1999
• Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
  Journal of Clinical Investigation, 1999
• Correction of Enzymatic and Lysosomal Storage Defects in Fabry Mice by Adenovirus-Mediated Gene Transfer
  Human Gene Therapy, 1999
• Persistence of an [E1-, Polymerase-] Adenovirus Vector Despite Transduction of a Neoantigen into Immune-Competent Mice
  Human Gene Therapy, 1999
• Adenovirus-Mediated Transfer of Human Acid Maltase Gene Reduces Glycogen Accumulation in Skeletal Muscle of Japanese Quail with Acid Maltase Deficiency
  Human Gene Therapy, 1998
• Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.
  Journal of Clinical Investigation, 1998
• Retroviral Transfer of Acidα-Glucosidase cDNA to Enzyme-Deficient Myoblasts Results in Phenotypic Spread of the Genotypic Correction by Both Secretion and Fusion
  Human Gene Therapy, 1997
• Enzyme Replacement Therapy
  Clinical Pediatrics, 1997
• Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐Glucosidase
  European Journal of Biochemistry, 1995